Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Testoni

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Journal of Hepatology|May 23, 2024
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytesFleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
The Journal of Infectious Diseases|April 16, 2024
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir TherapyLorin Begré, Anders Boyd, Marie-Laure Plissonnier, et al.
Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.
Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.
Journal of Hepatology|November 30, 2019
Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772]Marc Bonnin, Nadim Fares, Barbara Testoni, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
Journal of Hepatology|January 26, 2023
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanismsJulie Lucifora, Dulce Alfaiate, Caroline Pons, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 13, 2023
Hepatitis B Virus Targets Lipid Transport Pathways to Infect HepatocytesKnud Esser, Xiaoming Cheng, Jochen M Wettengel, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Hepatology|May 23, 2024
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytesFleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
The Journal of Infectious Diseases|April 16, 2024
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir TherapyLorin Begré, Anders Boyd, Marie-Laure Plissonnier, et al.
Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.
Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.
Journal of Hepatology|November 30, 2019
Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772]Marc Bonnin, Nadim Fares, Barbara Testoni, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
Journal of Hepatology|January 26, 2023
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanismsJulie Lucifora, Dulce Alfaiate, Caroline Pons, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 13, 2023
Hepatitis B Virus Targets Lipid Transport Pathways to Infect HepatocytesKnud Esser, Xiaoming Cheng, Jochen M Wettengel, et al.
Pageof 10